Protein tyrosine phosphatase receptor type delta (PTPRD) suppresses the expression of PD-L1 in human hepatocellular carcinoma by down-regulating STAT3 | Zendy

Qiuhua Meng | Zendy; Jing Tian | Zendy; Feizhang Qin | Zendy; Xuejing Huang | Zendy; Dan Zhu | Zendy; Xiang Bangde | Zendy; Min Dong | Zendy

Open Access

Protein tyrosine phosphatase receptor type delta (PTPRD) suppresses the expression of PD-L1 in human hepatocellular carcinoma by down-regulating STAT3

Author(s) -

Qiuhua Meng,

Jing Tian,

Feizhang Qin,

Xuejing Huang,

Dan Zhu,

Xiang Bangde,

Min Dong

Publication year - 2020

Publication title -

translational cancer research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.254

H-Index - 30

eISSN - 2219-6803

pISSN - 2218-676X

DOI - 10.21037/tcr-20-2425

Subject(s) - cancer research , protein tyrosine phosphatase , hepatocellular carcinoma , transfection , gene knockdown , downregulation and upregulation , carcinogenesis , western blot , dual specificity phosphatase , phosphatase , blot , biology , cell culture , gene , phosphorylation , microbiology and biotechnology , biochemistry , genetics

School of Pharmacy, Guangxi Medical University, Nanning, China; Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China Contributions: (I) Conception and design: M Dong; (II) Administrative support: M Dong; (III) Provision of study materials or patients: M Dong, B Xiang; (IV) Collection and assembly of data: Q Meng, J Tian, X Huang; (V) Data analysis and interpretation: F Qin, D Zhu; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Min Dong. School of Pharmacy, Guangxi Medical University, Nanning 530021, China. Email: dongmin0217@sina.com.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research